MicroRNA-543 promotes the proliferation and invasion of clear cell renal cell carcinoma cells by targeting Kruppel-like factor 6

被引:32
作者
Yang, Fan [1 ]
Ma, Jianjun [1 ]
Tang, Qisheng [1 ]
Zhang, Wei [1 ]
Fu, Qiang [1 ]
Sun, Jinbo [2 ]
Wang, He [1 ]
Song, Bin [1 ]
机构
[1] Fourth Mil Med Univ, Tangdu Hosp, Dept Urol, Xian 710038, Shaanxi, Peoples R China
[2] Fourth Mil Med Univ, Dept Urol, Xian 710032, Shaanxi, Peoples R China
关键词
Clear cell renal cell carcinoma; KLF6; miR-543; p21; TUMOR-SUPPRESSOR GENE; PROSTATE-CANCER; GASTRIC-CANCER; KLF6; EXPRESSION; MIR-543; KRUPPEL-LIKE-FACTOR-6; OVEREXPRESSION; PROGNOSIS; APOPTOSIS;
D O I
10.1016/j.biopha.2017.10.136
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
MicroRNA-543 (miR-543) has been suggested as an important regulator of the development and progression of various cancer types. However, the role and biological function of miR-543 in clear cell renal cell carcinoma (ccRCC) remains unclear. Here, we found that miR-543 expression was significantly increased in tumor tissues from ccRCC patients and ccRCC cell lines. We found that overexpression of miR-543 markedly promoted the proliferation and invasion of ccRCC cells, whereas suppression of miR-543 had the opposite effects. Kruppel-like factor 6 (KLF6) was identified as a target gene of miR-543. Furthermore, we found that miR-543 negatively regulates the expression of KLF6 and p21 in ccRCC cells. Overexpression of KLF6 markedly attenuated the oncogenic effect of miR-543 overexpression. Moreover, knockdown of KLF6 significantly reversed the antitumor effect of miR-543 inhibition. Overall, our results demonstrate that miR-543 promotes the proliferation and invasion of ccRCC cells by targeting KLF6 and suggest that miR-543 may serve as a potential therapeutic target for treatment of ccRCC.
引用
收藏
页码:616 / 623
页数:8
相关论文
共 47 条
  • [1] Al-Ali BM, 2012, ANTICANCER RES, V32, P3727
  • [2] A Systematic Review of Sequencing and Combinations of Systemic Therapy in Metastatic Renal Cancer
    Albiges, Laurence
    Choueiri, Toni
    Escudier, Bernard
    Galsky, Matthew
    George, Dan
    Hofmann, Fabian
    Lam, Thomas
    Motzer, Robert
    Mulders, Peter
    Porta, Camillo
    Powles, Thomas
    Sternberg, Cora
    Bex, Axel
    [J]. EUROPEAN UROLOGY, 2015, 67 (01) : 100 - 110
  • [3] [Anonymous], ONCOTARGET
  • [4] [Anonymous], UROL ONCOL
  • [5] PAQR3 overexpression suppresses the aggressive phenotype of esophageal squamous cell carcinoma cells via inhibition of ERK signaling
    Bai, Ge
    Chu, Jianhu
    Eli, Mayinur
    Bao, Yongxing
    Wen, Hao
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2017, 94 : 813 - 819
  • [6] RETRACTED: miR-543 is up-regulated in gefitinib-resistant non-small cell lung cancer and promotes cell proliferation and invasion via phosphatase and tensin homolog (Retracted Article)
    Bi, Mingjun
    Chen, Wei
    Yu, Hongmei
    Wang, Jinxiu
    Ding, Fang
    Tang, Dong Jing
    Tang, Cuiyan
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 480 (03) : 369 - 374
  • [7] Renal cell carcinoma
    Cairns, Paul
    [J]. CANCER BIOMARKERS, 2011, 9 (1-6) : 461 - 473
  • [8] Deletion, mutation, and loss of expression of KLF6 in human prostate cancer
    Chen, CS
    Hyytinen, ER
    Sun, XD
    Helin, HJ
    Koivisto, PA
    Frierson, HF
    Vessella, RL
    Dong, JT
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (04) : 1349 - 1354
  • [9] MicroRNA 543 suppresses breast cancer cell proliferation, blocks cell cycle and induces cell apoptosis via direct targeting of ERK/MAPK
    Chen, Po
    Xu, Wentao
    Luo, Yi
    Zhang, Yi
    He, Yi
    Yang, Shuo
    Yuan, Zhijun
    [J]. ONCOTARGETS AND THERAPY, 2017, 10 : 1423 - 1431
  • [10] Growth inhibitory effect of Kruppel-like factor 6 on human prostatic carcinoma and renal carcinoma cell lines
    Cheng, Xian-Feng
    Li, Di
    Zhuang, Min
    Chen, Zhao-Yan
    Lu, De-Xiang
    Hattori, Toshio
    [J]. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 216 (01) : 35 - 45